reference/568804

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/568804

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	523
issn	1078-0432 1557-3265
issueIdentifier	2
pageRange	515-523
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	515
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_375335e0a67a0ebec7a7e558531b0f47
bibliographicCitation	Xu J, Zhang Y, Jia R, Yue C, Chang L, Liu R, Zhang G, Zhao C, Zhang Y, Chen C, Wang Y, Yi X, Hu Z, Zou J, Wang Q. Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study. Clin Cancer Res. 2019 Jan 15;25(2):515–23. doi: 10.1158/1078-0432.ccr-18-2484. PMID: 30348638.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3226f1c153114f3a1d750da6c2c1051 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2212-0268 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bced3033bbc0b3c3c609ee9cbb54989 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3344f3ef261b2ed4c5537c50a4c5f822 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3924c55047e9ca5628f9419a3ec0547 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e86012ae9cc5c9b6101e2c8578afb7be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e10caff9365eae557f7d475d2191daf1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecac9dbea2354ee0afb8ef4df100ec36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbd47a9f0ce44dce61009fac2f776dfe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13d9535b7d114788449ee0147090a6fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8854a91ebb6991a59270b2792cd9b56d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5ebbc759d6863732a6281d18c33ae12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55b055a7fcce354aa5b0824fcb2ea64b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c2d3b3071bf3c8ea1d8462c271b99eb
date	2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-18-2484 https://pubmed.ncbi.nlm.nih.gov/30348638
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M000626416 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0551682 http://id.nlm.nih.gov/mesh/M000651317
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D004943Q000473 http://id.nlm.nih.gov/mesh/D006528Q000188 http://id.nlm.nih.gov/mesh/D008113Q000188 http://id.nlm.nih.gov/mesh/D004938Q000188 http://id.nlm.nih.gov/mesh/D013274Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D015415 http://id.nlm.nih.gov/mesh/D000074322Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D061067Q000008 http://id.nlm.nih.gov/mesh/D008113Q000401 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006528Q000209 http://id.nlm.nih.gov/mesh/D006528Q000175 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011725Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006528Q000401 http://id.nlm.nih.gov/mesh/D008113Q000209 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D008113Q000175 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D058990 http://id.nlm.nih.gov/mesh/D004938Q000209 http://id.nlm.nih.gov/mesh/D004938Q000175 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D013274Q000175 http://id.nlm.nih.gov/mesh/D013274Q000401 http://id.nlm.nih.gov/mesh/D013274Q000209
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_114dde61ee8708c9c30c287ea2b919e1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131750276 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11315474 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45139106

Total number of triples: 84.